ProNAi Wins $3.3 Million Funding From Michigan Economic Development Corporation - MEDC; Pioneer in DNAi-Based Drug Development Granted Top Funding Award In Life Sciences Category Of Michigan’s 21st Century Jobs Fund

KALAMAZOO, Mich.--(BUSINESS WIRE)--Sept. 12, 2006--ProNAi Therapeutics, Inc., a biopharmaceutical company pioneering a new class of nucleic-acid drugs based on DNA interference (DNAi), today announced that it has been granted a $3.3 million funding award from the Michigan Economic Development Corporation.